More Than a Score: What Rectal Cancer Survivors Taught Us About Recovery

Published in Cancer and Surgery

Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

What matters more after rectal cancer surgery: the score we record, or the experience our patients describe?

 

More than half of the patients in our study had severe bowel dysfunction after rectal cancer surgery. However, nearly three-quarters still described themselves as satisfied with their bowel function.

This unexpected finding challenged a question we often assume we already know the answer to: do symptom scores always reflect how patients actually feel?

For many people diagnosed with rectal cancer, one of the biggest worries is whether they will need a permanent stoma. Fortunately, sphincter-preserving surgery has transformed rectal cancer care. By avoiding a permanent stoma, it offers patients the possibility of maintaining normal defecation.

However, life after surgery can come with its own challenges.

Some patients experience changes in bowel habits after surgery. They may need to use the toilet more frequently (frequency), have a sudden urge to go (urgency), pass stools multiple times within a short period (clustering), pass stool in small, unsatisfying installments (fragmentation), or occasionally struggle with leakage (incontinence). These symptoms are collectively known as Low Anterior Resection Syndrome (LARS).

The LARS score, a validated patient-reported outcome measure, is widely used to quantify these symptoms and has consistently been associated with impaired quality of life. Higher scores indicate a greater impact on bowel function. In our study, we wanted to understand not only what the scores showed, but also how patients themselves felt about their lives after surgery.

 

What did we study?

We evaluated 42 Indian patients who had undergone sphincter-preserving surgery for rectal cancer - a population the LARS literature has largely overlooked.

We found that bowel symptoms after surgery were common:

  • 4% of patients had major LARS, meaning they experienced more severe bowel dysfunction.
  • 2% had minor LARS.
  • 4% had no LARS symptoms.
  • Patients with tumors located closer to the anal opening were more likely to have worse LARS scores.
  • Those undergoing lower rectal resections also tended to report more severe symptoms.

These findings were in line with what previous studies around the world have shown.

 

Nevertheless, another result surprised us.

When the numbers and the patient's experience do not match

Despite experiencing bowel symptoms:

  • 8% of patients reported that they were satisfied with their bowel function overall.
  • Even among patients with major LARS, 63.6% still reported feeling satisfied and having adapted well to life after surgery.

In other words, a high symptom score did not always mean that patients felt their quality of life was poor.

 

Why Might This Happen?

Several factors may contribute to this disconnect.

 

Survival often outweighs inconvenience.

Many patients expressed gratitude simply for being cancer-free. After confronting a life-threatening diagnosis, occasional urgency or increased frequency may be perceived as a reasonable trade-off.

 

Adaptation changes perception

Patients frequently develop coping mechanisms over time. Adjusting diet, scheduling daily activities around bowel habits, and learning about symptom triggers can improve confidence and satisfaction despite persistent symptoms.

 

Family and social support matter

In many Indian households, strong family support systems may ease the practical and emotional burden associated with bowel dysfunction.

 

Cultural context may influence symptom interpretation.

The LARS questionnaire was developed and validated predominantly in Western populations. It places significant emphasis on symptoms such as urgency and clustering.

Whether lifelong differences in diet, bowel habits, expectations of normality, and sociocultural attitudes influence how Indian patients interpret these symptoms remains uncertain. This hypothesis warrants further investigation in larger, multicentre cohorts.

 

What Does This Mean for Clinical Practice?

Our findings highlight an important message:

Scores matter, but so do conversations.

 

A high LARS score should prompt clinicians to explore how symptoms affect an individual's daily life rather than assume poor quality of life.

Conversely, patients who report satisfaction despite major LARS should not be dismissed as "doing well" without ongoing support and surveillance.

The score provides structure and comparability. The patient's voice provides meaning.

 

Looking Ahead

This was a single-center study involving a relatively small cohort, and our findings should be interpreted within these limitations. Larger prospective studies are needed to determine whether these observations are reproducible across diverse populations.

 

Nevertheless, our patients reminded us of an important truth that can easily be overlooked in survivorship care:

Recovery after cancer is not defined solely by the absence of symptoms. It is also shaped by resilience, adaptation, expectations, and the personal meaning individuals attach to their experiences.

 

As clinicians, we should continue to carefully measure bowel function.

However, we should also ask a simpler question:

"How are you living with it?"

Because the score tells us something important.

And so does the person sitting across from us.

Read the full article.

Our study, "Functional Outcomes After Sphincter-Preserving Surgery for Rectal Cancer: Exploring the Relationship Between LARS Severity and Patient Satisfaction in an Indian Cohort", is now available online through Springer Nature.

 

For researchers, clinicians, and survivorship specialists interested in patient-reported outcomes after rectal cancer surgery, we invite you to read the complete manuscript:

Article link: https://link.springer.com/article/10.1007/s12672-026-05000-5

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Rectal Cancer
Life Sciences > Biological Sciences > Cancer Biology > Cancers > Gastrointestinal Cancer > ColoRectal Cancer > Rectal Cancer
Colorectal Surgery
Life Sciences > Health Sciences > Surgery > Colorectal Surgery
  • Discover Oncology Discover Oncology

    This is a fully open access general oncology journal that aims to provide a unified forum for researchers and clinicians. The journal spans from basic and translational science, to preclinical, clinical, and epidemiology, and welcomes content that interfaces at all levels of cancer research.

Related Collections

With Collections, you can get published faster and increase your visibility.

Prostate Cancer - Advances in Diagnosis and Treatment

Prostate cancer remains one of the most prevalent malignancies among men globally, accounting for a significant proportion of cancer-related morbidity and mortality. With increasing life expectancy and improved diagnostic techniques, the incidence and detection rates of prostate cancer continue to rise, highlighting the critical need for advances in both diagnostic and therapeutic approaches. Recent breakthroughs in molecular biology, imaging technologies, and genetic profiling have significantly enhanced early detection and prognostic accuracy, allowing for more personalized patient care.

This Collection aims to present comprehensive insights into recent developments and cutting-edge research in prostate cancer diagnosis and treatment. Key topics include novel biomarkers for early detection, advances in imaging modalities such as multiparametric MRI and PET-PSMA, genomic and epigenetic factors influencing disease progression, and emerging therapeutic strategies including robotic-assisted surgery, radiotherapy advancements, immunotherapy, and precision medicine approaches. Additionally, the collection will explore mechanisms of resistance to therapy, the role of tumor microenvironment in disease evolution, and strategies to overcome treatment barriers. We invite contributions focusing on translational and clinical research, innovative diagnostic methods, therapeutic innovations, and studies that bridge fundamental discoveries with clinical application to improve patient outcomes in prostate cancer.

Keywords: prostate cancer, biomarkers, imaging, genomics, precision medicine, robotic surgery, radiotherapy, immunotherapy, tumor microenvironment

Publishing Model: Open Access

Deadline: Jan 04, 2027

The Evolving Landscape of Lung Cancer: Advances in Diagnosis, Treatment Strategies, and Simultaneous Care

Lung cancer remains one of the leading causes of cancer-related mortality worldwide, although recent years have seen remarkable progress in its clinical management. This Collection aims to deepen the evolving landscape of lung cancer through a comprehensive lens, including early diagnosis, molecular profiling (through liquid and tissue), therapeutic innovation, and simultaneous care strategies. The Collection will gather original research, reviews, short reports or letters and case studies focused on:

advances in early detection and biomarker discovery and development;

the evolution of precision oncology and molecular profiling;

updates on systemic therapies, including immunotherapy and targeted agents;

novel treatment combination strategies,

the increasing integration of simultaneous care into multidisciplinary models for improving patient outcomes.

Keywords: lung cancer; precision oncology; immunotherapy; molecular diagnostics; simultaneous care

Publishing Model: Open Access

Deadline: Dec 04, 2026